About Joo Hee Kwak
Form D filings for Ingenia Therapeutics in 2024 list Joo Hee Kwak as director.
Joo Hee Kwak first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Joo Hee Kwak in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joo Hee Kwak works with at each company, as listed on that company's latest Form D.
Ingenia Therapeutics Inc. · Form D, Jun 21, 2024
SK
Sang Gyun Kim
Director
EF
Eric Furfine
Director
SH
Sangyeul Han
President and director
KC
Kwang Ho Cheong
Director